Liquidia (LQDA) Gross Profit (QoQ) (2021 - 2026)
Powered by 
Analysis
Liquidia (LQDA) Gross Profit (QoQ) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.43 Bn | 625.67 Bn | 17.26 Bn |
| 2 | AbbVie | 442.46 Bn | 435.89 Bn | 12.70 Bn |
| 3 | Merck | 366.77 Bn | 359.63 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.59 Bn | 258.90 Bn | 11.24 Bn |
| 5 | Pfizer | 159.14 Bn | 147.45 Bn | 10.94 Bn |
| 6 | Sanofi | 52.40 Bn | 45.02 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - |
| 8 | Incyte | 25.38 Bn | 20.85 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.53 Bn | 18.87 Bn | 683.80 Mn |
| 10 | Liquidia | 6.11 Bn | 5.82 Bn | 160.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 32.13% |
| Mar 31, 2026 | 40.17% |
| Dec 31, 2025 | 66.93% |
| Sep 30, 2025 | 589.82% |
| Jun 30, 2025 | 370.68% |
| Mar 31, 2025 | 2.56% |
| Dec 31, 2024 | -45.79% |
| Sep 30, 2024 | 33.10% |
| Jun 30, 2024 | 43.92% |
| Mar 31, 2024 | -57.46% |
| Dec 31, 2023 | 13.84% |
| Sep 30, 2023 | -24.47% |
| Jun 30, 2023 | 7.19% |
| Mar 31, 2023 | -17.72% |
| Dec 31, 2022 | 92.41% |
| Sep 30, 2022 | -23.91% |
| Jun 30, 2022 | 13.90% |
| Mar 31, 2022 | 12.41% |
| Dec 31, 2021 | 8.74% |
| Sep 30, 2021 | -14.01% |